Surgeon Laments Limited Availability Of Cross-Linking In US | OphthalmologyWeb: The Ultimate Online Resource for Ophthalmologists

Thursday, November 25, 2010

Email

Comments

Ocular Surgery News

Although UV-riboflavin collagen cross-linking is currently undergoing clinical trials in the United States, one surgeon expressed dissatisfaction that the procedure still lacks U.S. Food and Drug Administration approval for treating corneal disorders such as ectasia.

Corneal and Refractive Diagnostics »

All of the following are risk factors for the disorder shown EXCEPT:
1. iris color
2. obesity
3. smoking
4. hypertension
Check The Answer

Volk iNview
iPhone Fundus Camera The Volk iNview ... view product
Smartphone-Based Retinal Screening System
D-EYE, The Modern Day Digital ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us